Harrison.ai
Harrison.ai develops clinical AI, including the Harrison.rad.1 radiology vision-language model and chest X-ray and CT decision-support tools, for radiologists and pathologists. Its products are used in more than 40 countries. Customers include health systems such as the UK NHS and imaging groups such as I-MED. It sells software to hospitals and imaging providers and has launched Frontier Radiology, a US teleradiology service that uses its technology. It closed a $112M Series C in February 2025 at a reported valuation of about US$551M, bringing total funding to roughly $333M. Forbes Australia reported 2026 annual revenue of about $28M and about 200 employees after layoffs.
Funding
Every round, secondary, debt facility or acquisition involving Harrison.ai that AI Lounge tracks, newest first.
No rounds recorded yet.
Members see every AI company on AI Lounge with revenue, funding, valuation and investors, searchable and sortable, free.
Create my free account →Log in